Monday - July 26, 2021
Public Citizen: Letter - Woodcock Must Be Investigated as Part of IG's Probe Into Aducanumab's Approval
July 14, 2021
WASHINGTON, July 14 (TNSPol) -- Public Citizen issued the following news release:

Acting U.S. Food and Drug Administration (FDA) Commissioner Janet Woodcock must be investigated as part of the independent investigation of the approval of aducanumab for treatment of Alzheimer's disease following the unprecedented, inappropriately close collaboration between Biogen and the agency to bring the drug to market, Public Citizen said in a letter to Christi A. Grimm, Principal Deputy Inspect . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products